NORTHERN TRUST CORP - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 67 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 1.4%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$257,000
-24.6%
80,615
+0.7%
0.00%
Q1 2022$341,000
-3.4%
80,053
+5.3%
0.00%
Q4 2021$353,000
+13.5%
76,006
-2.4%
0.00%
Q3 2021$311,000
-2.2%
77,839
+4.7%
0.00%
Q2 2021$318,000
-67.1%
74,312
-67.4%
0.00%
Q1 2021$967,000
-0.5%
228,088
-8.9%
0.00%
Q4 2020$972,000
-12.0%
250,427
-8.6%
0.00%
Q3 2020$1,104,000
-19.5%
273,948
-14.9%
0.00%
Q2 2020$1,371,000
+9.5%
321,968
+7.9%
0.00%
Q1 2020$1,252,000
+6.9%
298,285
+0.1%
0.00%
Q4 2019$1,171,000
-55.6%
298,063
-0.6%
0.00%
-100.0%
Q3 2019$2,639,000
+3.3%
299,889
+8.6%
0.00%0.0%
Q2 2019$2,555,000
+44.8%
276,154
+0.7%
0.00%
Q1 2019$1,764,000
-37.2%
274,274
-7.9%
0.00%
-100.0%
Q4 2018$2,809,000
-54.1%
297,893
-2.1%
0.00%0.0%
Q3 2018$6,125,000
-29.8%
304,226
+1.8%
0.00%
-50.0%
Q2 2018$8,719,000
+16.9%
298,883
+19.3%
0.00%0.0%
Q1 2018$7,459,000
-7.7%
250,501
-0.3%
0.00%0.0%
Q4 2017$8,084,000
-7.7%
251,193
-0.3%
0.00%0.0%
Q3 2017$8,758,000
+14.6%
251,844
-1.9%
0.00%0.0%
Q2 2017$7,641,000
+26.1%
256,640
+26.4%
0.00%0.0%
Q1 2017$6,058,000
+75.1%
202,962
+2.8%
0.00%
+100.0%
Q4 2016$3,460,000
-22.2%
197,420
+5.6%
0.00%0.0%
Q3 2016$4,447,000
+46.6%
186,972
-1.4%
0.00%0.0%
Q2 2016$3,034,000
-14.8%
189,583
+11.3%
0.00%0.0%
Q1 2016$3,562,000
-21.2%
170,290
+1.7%
0.00%0.0%
Q4 2015$4,520,000
+15.2%
167,408
+18.5%
0.00%0.0%
Q3 2015$3,925,000
+292.9%
141,219
+246.4%
0.00%
Q2 2015$999,000
+146.7%
40,769
+84.3%
0.00%
Q1 2015$405,000
+34.6%
22,125
+35.5%
0.00%
Q4 2014$301,000
+110.5%
16,325
+9.5%
0.00%
Q3 2014$143,00014,9130.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders